| Date |
Description |
Institution |
# Students |
| 8/2013 - Present |
Ph.D. Dissertations Directed |
UTHSCSA |
|
|
| 5/2013 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 5/2013 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 9/2012 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 3/2012 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 1/2012 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 10/2011 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 10/2011 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 7/2011 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 9/2010 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center |
|
|
| 7/2010 - Present |
Individual Instruction |
The University of Texas Health Science Center, San Antonio, TX |
|
|
| 6/2010 - Present |
Membership on Supervising Committee |
The University of Texas Health Science Center |
|
|
| 1/2010 - Present |
Pre-Doctoral Student Supervision |
The University of Texas Health Science Center, San Antonio, TX |
|
|
| 9/2009 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 6/2009 - Present |
Introduction to Clinical Laboratory Sciences |
The University of Texas Health Science Center |
18 students |
| Lectured on recent advances in natural products for cancer management |
| 3/2009 - Present |
Cancer Biology Core II |
The University of Texas Health Science Center |
11 students |
| Lectured on GU malignancies with special reference to prostate cancer and treatment strategies |
| 3/2009 - Present |
Pre-Doctoral Student Supervision |
The University of Texas Health Science Center, San Antonio TX |
|
|
| 9/2008 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 6/2008 - Present |
Cancer Biology Core II |
The University of Texas Health Science Center |
3 students |
| Lectured on molecular events associated with prostate cancer development, detection methods and preventive strategies |
| 4/2008 - Present |
Individual Instruction |
The University of Texas Health Science Center, San Antonio, TX |
|
|
| 1/2007 - Present |
Individual Instruction |
The University of Texas Health Science Center, San Antonio, TX |
|
|
Journal Article |
| Chen C-L, Mahalingam D, Osmulski PA, Jadhav RR, Wang C-M, Leach RJ, Weitman SD, Kumar P, Sun L-Z, Gaczynska ME, Thompson J, Huang TH. Single-cell Analysis of Circulating Tumor Cells Identifies Cumulative Expression Patterns of EMT-related Genes in Metastatic Prostate Cancer The Prostate 2013 Jan;73(8):813-826.
|
| Li, G, Rivas, P, Bedolla, R, Thapa, D, Reddick RL, Ghosh R, Kumar P. Dietary Resveratrol Prevents Development of High-Grade Prostatic Intraepithelial Neoplastic Lesions: Involvement of SIRT1/S6K Axis Cancer Prevention Research 2012 Jan;.
|
| Bedolla RG, Gong J, Prihoda TJ, Yeh IT, Thompson IM, Ghosh R, Kumar AP. Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence PLOS ONE 2012 Jan;7(9).
|
| Ghosh, R., Graham, H., Rivas, P., Tan, J-X., Crosby, K., Bhaskaran, S., Schoolfield, J., Banu, J., Fernandes, G., Yeh, I-Tien and Kumar, A.P. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management Anticancer Research 2010 Jan;30:847-857.
|
Abstract |
| Batth IS, Gong J, Kumar, Ph.D. AP. Novel interaction between FLIP/DAPK: role for RON in androgen-independent prostate cancer; 2013 Apr. (American Association for Cancer Research 104th Annual Meeting, Washington, DC).
|
| Batth IS, Gong J, Kumar, Ph.D. AP. RON Kinase Propagates Prostate Tumorigenesis through Interations with AR and FLIP; 2012 Nov. (Advances in Cell Signaling, Cancer Prevention & Therapy 13th Annual Meeting, South Padre Island, Tx).
|
| Gong J, Xie J, Batth IS, Freeman JW, Kumar, Ph.D. AP. Disruption of NFB/Stat3 interaction as a potential therapeutic avenue for pancreatic cancer management; 2012 Jun. (Pancreatic Cancer: Progress and Challenges, Lake Tahow, NV).
|
| Batth IS, Gong J, Bedolla RG, Weintraub ST, Kumar, Ph.D. AP. 2-Methoxyestradiol targets RON kinase and FLIP to inhibit epithelial-mesenchymal transition in Prostate Cancer; 2012 Apr. (American Association for Cancer Research 103rd Annual Meeting, Chicago, IL).
|
| Batth IS, Weintraub ST, Kumar, Ph.D. AP. 2-Methoxyestradiol targets RON kinase and FLIP to inhibit epithelial-mesenchymal transition in Prostate Cancer; 2011 Nov. (Advances in Cell Signaling, Cancer Prevention).
|
| Gong, J., Batth, I.S. and Kumar, A.P. Jak/Stat signaling: a potential target for pancreatic cancer management; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| Xie, J., Rivas, P., Soundararajan, A., David, M.D., Yeh, I-T., Ghosh, R and Kumar, A.P. Interactions among transcription factors as a potential mechanism for inhibiting castrate-resistant prostate cancer (CRPCa) in transgenic adenocarcinoma of mouse prostate (TRAMP) through regulation of FLIP; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| Gong J, Batth IS, Kumar, Ph.D. AP. Jak/STAT3 signaling: A potential target for pancreatic cancer management; 2011 Apr. (American Associaton for Cancer Research 102 nd Annual Meeting, Orlando, FL).
|
| Xie, J., Ghosh, R. and Kumar, A.P. 2-Methoxyestradiol (2-ME2) induces microRNA alterations in prostate cancer cells: Role for miRs in 2-ME2-induced biological effects; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| A. Gupta, M. Mann, A.P. Kumar, B.O. Oyajobi. Anti-tumor effect of Nextrutine, a Phellodendron amurense Bark Extract; 2011 Jan. (102ND Annual meeting of the American Association for Cancer Research, April 2011).
|
| Kumar, A.P., Swanson, G.P., Thompson, I.M. and Ghosh, R. Molecular targeted approaches for cancer management; 2011 Jan. (Invited presentation at Plenary session at 98th Indian Science Congress January 2011).
|
| Gong, J., Freeman, J.W. and Kumar, A.P. NFkB and Stat3 interaction: a potential target for pancreatic cancer management; 2010 Nov. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy).
|
| Jingjing Gong, James W Freeman and Kumar, Ph.D. AP. NF-kappaB and Stat3 interaction: a potential target for pancreatic cancer management; 2010 Nov. (Advances in cell signaling, Cancer prevention and therapeutics Annual Meeting, South Padre Island, Tx).
|
| Kumar, S., Ghosh, R. and Kumar, A.P. 2-Methoxyestradiol inhibits proliferation and induces apoptosis through modulation of miR-7/FLIP signaling in prostate cancer cells; 2010 May. (101st annual meeting of the American Association of Cancer Research Washington DC, April 17-21 2010).
|
| Jingjing Gong, James W Freeman and Kumar, Ph.D. AP. Enhanced inhibition of proliferation of pancreatic cancer cells by combination of Gemcitabine and Phellodendron amurense bark extract:: target identification; 2010 Apr. (American Association for Cancer Research Annual Meeting. Orlando, FL).
|
| Li, G., Ghosh, R., Kumar, A.P. Differential effects of resveratrol-induced SIRT1 in prostate cancer: A novel therapuetic target; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Kumar, A.P., Xie, J., Graham, H., Rivas, P., Li, G,. Robson, C.H., Gong, J., Garapati, K,. Swanson, G.P., Thompson, I.M., Papanikolaou, N., Yeh, I-T. and Ghosh, R. Bench to bedside application of Phellodendron amurense bark extract: myth or reality?; 2010 Jan. (Invited presentation at 2nd International ICR symposium December 2010).
|
| Xie, J., Ghosh R., and Kumar AP. 2010. 2-Methoxyestradiol modulated microRNAs in prostate cancer cells. 12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy. November 12-13th 2010; 2010 Jan.
|
| Graham, H.L., Kumar, A.P. and Ghosh, R. mTOR mediated signaling in the management of malignant melanoma; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy).
|
| Xie, J., Ghosh, R. and Kumar, A.P. FLIP transcriptional deregulation: A potential mechanism for development of androgen independent prostate cancer; 2010 Jan. (101st annaul meeting of the American Association of Cancer Research, Washington DC, April 17-21, 201).
|
| Rita Ghosh, Emily Clark, Heather L Graham, Addanki P Kumar. NexrutineR: a novel agent for malignant melanoma 7th International Melanoma Congress, November 4-7, 2010 Sydney, Australia Pigment Cell and Melanoma Research 23: 952-53; 2010 Jan.
|
| Graham, HL., Kumar AP and Ghosh, R. mTOR mediated signaling in the management of malignant melanoma. 2010; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer).
|
| Ghosh, R., Clark, E., Graham, H. and Kumar, A.P. NexrutineR: A novel agent for malignant melanoma; 2010 Jan. (7th International Melanoma Congress, Sydney, Nov 4-7, 2010).
|
| Gong, J., Freeman JW and Kumar, AP. NFkB and Stat3 interaction: a potential target for pancreatic cancer management. 12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy. November 12-13th 2010; 2010 Jan.
|
| Kumar, S.A., Ghosh, R., Kumar, A.P. 2-Methoxyestradiol inhibits proliferation and induces apoptosis through modulation of miR-7/FLIP signaling in prostate cancer cells; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Ghosh, R., Clark, E., Graham, H.L. and Kumar, A.P. NexrutineR: a novel agent for malignant melanoma; 2010 Jan. (7th International Melanoma CongressSydney, Australia Pigment Cell and Melanoma Research).
|
| Xie, J., Ghosh, R., Kumar, A.P. FLIP transcriptional regulation: A potential mechanism for development of androgen independent prostate cancer; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Polnaszek, N., Soomro, N., Bermejo, C.E., Kumar, A.P. and Ghosh, R. 8-methyl-N-vannillyl 6-nonemide (capsaicin) induces apoptosis in bladder cancer cells independent of p53 status: implications for therapy; 2010 Jan. (Annual Meeting of the American Urological Association, San Francisco, May 29-June 3, 2010).
|
| Xie, J., Ghosh, R. and Kumar, Ph.D. AP. 2-Methoxyestradiol modulated microRNAs in prostate cancer cells; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer).
|
| George, S.K., Kumar, A.P. and Ghosh, R. Multiple roles of E2F1 in eugenol-induced DNA damage signaling and cell survival; 2009 Nov.
|
| Jingjing Gong, James W Freeman and Kumar, Ph.D. AP. Prostaglandin signaling: Target for pancreatic cancer; 2009 Nov. (Advances in cell signaling, Cancer prevention and therapeutics Annual Meeting, South Padre Island, Texas).
|
Review Article |
| Jingjing Gong, James W Freeman, Kumar, Ph.D. AP. Interaction between Jak/Stat3 and ROS generation in pancreatic cancer Advances in cell signaling, Cancer prevention and therapeutics Annual Meeting, South Padre Island, Tx 2011 Nov;.
|
| Kumar AP, Graham HL, Robson C, Thompson, IM and Ghosh R. Natural Products: Potential for developing Phellondendron amurense bark extract for prostate cancer management Mini-rev Med Chem 2010 Jan;10:388-397.
|
Not Specified |
| Kumar AP. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth ONCOTARGET 2014 May;.
|
| Kumar AP. Combined targeting of Stat3/NF B/Cox-2/EP4 for effective management of pancreatic cancer Clinical Cancer Research 2014 Mar;20.
|
| Kumar AP. Palmatine suppresses rpS6/NFκB/FLIP to inhibit growth and invasion in androgen independent prostate cancer cells Molecular Carcinogenesis 2014 Jan;.
|
| Kumar, Ph.D. AP. FLIP MOLECULAR SWITCH BETWEEN APOPTOSIS AND NECROPTOSIS MOLECULAR CARCINOGENESIS 2013 Jan;.
|
